Strategic partnership Leverage MedReleaf Australia's status as a wholly owned Aurora subsidiary with a growing cannabis product portfolio to co-market premium dried flower and sublingual products to Australian and New Zealand GPs and pharmacists.

R&D driven Capitalize on their strong focus on Research and Development to position new formulations and higher-THC products for qualified patients, offering trials or pilot programs with medical practitioners.

Cannabis expansion Target opportunities related to the expanding cannabis product line including pastilles and higher-THC dried products, aligning onboarding with clinics and specialty pharmacies serving medical cannabis patients.

Sustainability edge Highlight CleanHub partnership for plastic waste offset as a differentiator when engaging purchasers prioritizing ESG, offering co-branded sustainability initiatives and reporting.

Operational leverage Promote the asset-light, efficient operating model to distributors and retailers seeking reliable supply chains in Australia and New Zealand, with scalable SKU options aligned to GP and pharmacist buying cycles.